[HTML][HTML] Counting on COVID-19 vaccine: insights into the current strategies, progress and future challenges
R Kandimalla, P Chakraborty, J Vallamkondu… - Biomedicines, 2021 - mdpi.com
The emergence of a novel coronavirus viz., severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) in late 2019 and its subsequent substantial spread produced the …
2 (SARS-CoV-2) in late 2019 and its subsequent substantial spread produced the …
[HTML][HTML] SARS-CoV-2 targets and COVID-19 vaccines
AW Currier, MC Jeshurin, VB Sampson - COVID, 2021 - mdpi.com
Coronavirus disease-2019 (COVID-19) vaccines are being used across the globe to reduce
the risk of developing COVID-19, stop the transmission of severe acute respiratory syndrome …
the risk of developing COVID-19, stop the transmission of severe acute respiratory syndrome …
COVID‐19 vaccinations: the unknowns, challenges, and hopes
The entire world has been suffering from the coronavirus disease 2019 (COVID‐19)
pandemic since March 11, 2020. More than a year later, the COVID‐19 vaccination brought …
pandemic since March 11, 2020. More than a year later, the COVID‐19 vaccination brought …
The COVID-19 vaccine landscape
T Koch, A Fathi, MM Addo - Coronavirus Disease-COVID-19, 2021 - Springer
The history of vaccine development spans centuries. At first, whole pathogens were used as
vaccine agents, either inactivated or attenuated, to reduce virulence in humans. Safety and …
vaccine agents, either inactivated or attenuated, to reduce virulence in humans. Safety and …
[HTML][HTML] A review of the safety and efficacy of current COVID-19 vaccines
Z Huang, Y Su, T Zhang, N Xia - Frontiers of Medicine, 2022 - Springer
Vaccination is the most effective and feasible way to contain the Coronavirus disease 2019
(COVID-19) pandemic. The rapid development of effective COVID-19 vaccines is an …
(COVID-19) pandemic. The rapid development of effective COVID-19 vaccines is an …
[HTML][HTML] From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era
G Miao, Z Chen, H Cao, W Wu, X Chu, H Liu… - Biomedicine & …, 2023 - Elsevier
The COVID-19 pandemic has affected millions of people and posed an unprecedented
burden on healthcare systems and economies worldwide since the outbreak of the COVID …
burden on healthcare systems and economies worldwide since the outbreak of the COVID …
Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines
C Zhu, S Pang, J Liu, Q Duan - Drugs, 2024 - Springer
The COVID-19 pandemic has resulted in over 772 million confirmed cases, including nearly
7 million deaths, according to the World Health Organization (WHO). Leveraging rapid …
7 million deaths, according to the World Health Organization (WHO). Leveraging rapid …
[HTML][HTML] A COVID-19 vaccine: big strides come with big challenges
J Mellet, MS Pepper - Vaccines, 2021 - mdpi.com
As of 8 January 2021, there were 86,749,940 confirmed coronavirus disease 2019 (COVID-
19) cases and 1,890,342 COVID-19-related deaths worldwide, as reported by the World …
19) cases and 1,890,342 COVID-19-related deaths worldwide, as reported by the World …
[HTML][HTML] COVID-19 vaccines currently under preclinical and clinical studies, and associated antiviral immune response
With a death toll of over one million worldwide, the COVID-19 pandemic caused by SARS-
CoV-2 has become the most devastating humanitarian catastrophe in recent decades. The …
CoV-2 has become the most devastating humanitarian catastrophe in recent decades. The …
[HTML][HTML] COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development
R Singh, A Kang, X Luo, M Jeyanathan… - The FASEB …, 2021 - ncbi.nlm.nih.gov
The COVID‐19 pandemic has unfolded to be the most challenging global health crisis in a
century. In 11 months since its first emergence, according to WHO, the causative infectious …
century. In 11 months since its first emergence, according to WHO, the causative infectious …